Linda Narhi, PhD Amgen

Linda received her BS Chemistry from the Univ. of Michigan, and her PhD in Biological Chemistry from UCLA. She joined Amgen over 30 years ago, and has been involved in the characterization of protein therapeutics, especially higher order structure and protein aggregate and particles, throughout her career. She is currently a Scientific Executive Director in the Attribute Science group in Process Development.

Linda is a member of the USP expert committee on subvisible particle analysis for Biologics, and was the chair of the AAPS focus group on Protein Aggregation and Biological Consequences for the past 2 years. She has published extensively on the subjects of protein folding, stability, and aggregation, on potential immunogenicity of protein aggregates, and on biotherapeutic development.